Last reviewed · How we verify
NCT05456568: LAAH
LymphAssistTM at Home (LAAH)
NA trial testing LymphAssistTM Professional in Lymphedema Arm in 40 participants. Completed in 25 September 2023.
25 September 2023
Quick facts
| Lead sponsor | Swansea Bay University Health Board |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 6 July 2022 |
| Primary completion | 25 September 2023 |
| Estimated completion | 25 September 2023 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- LymphAssistTM Professional
Conditions studied
- Lymphedema Arm — all drugs for Lymphedema Arm →
- Lymphedema of Leg — all drugs for Lymphedema of Leg →
Sponsor
Swansea Bay University Health Board
Who can join
18 and older, any sex, with Lymphedema Arm or Lymphedema of Leg. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Lymphoedema is a life-long condition causing long-term swelling affecting people physically, mentally and socially. Daily self-management covers four main areas (skin care, activity / movement, compression and massage / light touch). Intensive clinic-based treatments are available alongside usual care, including intermittent pneumatic compression (IPC). Recent studies have explored the feasibility, acceptability and impact of home-based IPC. This study will further our understanding of home-based IPC in a Value-Based procurement study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05456568
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lymphedema Arm
Currently open trials in the same condition.
- NCT07043140 — Mobile Self-Management Training for Lymphedema Prevention · NA · active not recruiting
- NCT06783543 — Efficacy of Home-based Treatment for Breast Cancer-related Lymphedema · NA · active not recruiting
- NCT07233863 — Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer · NA · recruiting
- NCT06302361 — Lymphovenous Anastomosis for Breast Cancer Lymphedema · NA · active not recruiting
- NCT06082349 — The N-LVA Study: RCT Comparing LVA vs. Sham Surgery in Cancer-related Lymphedema · NA · recruiting
Other Swansea Bay University Health Board trials
Trials by the same sponsor.
- NCT07365072 — The PRIMROSE Trial · NA · recruiting
- NCT05322200 — The POST-ACS Study · Phase 4 · unknown
- NCT05163873 — ExPECT: Extraperitoneal End Colostomy Trial · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05456568 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Swansea Bay University Health Board
- Last refreshed: 30 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05456568.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing